Close Menu

digital PCR

It has been nearly a year since RainDance Technologies officially "launched" its digital PCR platform, RainDrop, by recruiting researchers to be part of an early-access program.

Monoquant, an Australian company spun out of Flinders University to commercialize molecular methods to monitor minimal residual disease in blood cancers, has developed a PCR-based DNA assay that can routinely detect one cancerous cell in 10 million normal cells in chronic myeloid

Life Technologies has received CE IVD marking for its Applied Biosystems QuantStudio Dx platform and launched the instrument in Europe.

This article has been updated from a previous version to note that the Center for Integrated Genomics is located in Foster City, Calif.

Bio-Rad Laboratories this week reported that it sold $5.2 million in digital PCR products in the third quarter, more than doubling digital PCR sales in the previous quarter and contributing to 3.6 percent overall Q3 growth at the company on a currency-neutral basis.

Fluidigm is launching four new consumable chips based on its integrated fluidic circuit technology, PCR Insider has learned.

Life Technologies remains the market leader in qPCR instrumentation and reagents, and pricing concerns around its qPCR business due to new low-price reagents from rival Illumina are "unwarranted" due to a relatively "sticky" reagent market, according to the results of a recent su

Digital PCR has the potential to supplant quantitative real-time PCR as the assay technology of choice for certain applications, particularly the detection and absolute quantification of low-level DNA targets in oncology and HIV research, industry stakeholders and early users sai

NEW YORK (GenomeWeb News) – RainDance Technologies and Integrated DNA Technologies today said they will collaborate to develop consumables for use on the RainDrop Digital PCR System.
Financial and other terms of the deal were not disclosed.

Pages

The New York Times looks at companies using genomic tools to try to quickly identify the cause of patients' infections.

The White House has asked for $2.5 billion in funding to address the COVID-19 outbreak, according to the Associated Press.

A resignation at the Marine Biological Laboratory highlights that institutions are unsure of how to handle researchers previously found to have violated codes of conduct, Nature News says.

In PNAS this week: immune responses that affect heart transplant rejection risk, gene variants associated with thiopurine toxicity, and more.